Fenfluramine
Fenfluramine is a pharmaceutical drug with 11 clinical trials. Currently 5 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
5
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fenfluramine for Adult Dravet Patients
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
Treatment of Refractory Infantile Spasms With Fenfluramine
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
Clinical Trials (11)
Fenfluramine for Adult Dravet Patients
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
Treatment of Refractory Infantile Spasms With Fenfluramine
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
Fenfluramine and Cognition
Predictive Values of Serotonergic Alterations for Outcome - 2
Cardiovascular System in Obesity: Effect of Treatment
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11